Cidara Therapeutics Inc (CDTX)

21.42 -1.09 (-4.84%) USD  |  NASDAQ  |  Dec 20, 11:44
More

Cidara Therapeutics Cost of Goods Sold (% of Quarterly Revenues)

Cost of Goods Sold (% of Quarterly Revenues) Chart

View Cost of Goods Sold (% of Quarterly Revenues) for CDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cost of Goods Sold (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cost of Goods Sold Definition

View Cost of Goods Sold Definition
Start Trial

Cost of Goods Sold (COGS) is the measure of direct costs related to the production of goods. Includes the cost of obtaining raw materials and direct labor costs.

Read full definition.

Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

View Cost of Goods Sold (% of Quarterly Revenues) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp --
GlycoMimetics Inc --
FibroGen Inc Upgrade
Cue Biopharma Inc --